Grifols

GRFS

0 Followers

$7.10

-2.74%

-$0.20

12 May

Upcoming Earnings

Market Cap.

P/E

Overview Metrics Financials

GRFS Fair Price

$3.46

Undervalued by 91.4%

To display the fair price of a share, you need to be a member of Bulios Black.

My Notes

Začít psát

Profile

Grifols, S.A. is a global Spanish pharmaceutical and biotechnology company specializing in the production of plasma-derived medicines and healthcare products. The company focuses on producing immunoglobulins, albumin, and other plasma-based products that are essential for the treatment of various diseases, including immunological and neurological disorders. Grifols also develops diagnostic tools and systems for hospitals and clinics. The company has a broad global presence and operates in over 30 countries worldwide.

Feed

There are no posts to show right now.